Education
About Us
Working with TipRanks
Follow Us
Siemens Healthineers AG Unsponsored ADR (SMMNY)
OTHER OTC:SMMNY
SMMNY Stock Chart & Stats
$26.02
--
Market closed
$26.02
--
Day’s Range― - ―
52-Week Range$23.42 - $29.14
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.52K
Market Cap
$54.44B
Enterprise Value$60.32B
Total Cash (Recent Filing)$2.14B
Total Debt (Recent Filing)$15.16B
Price to Earnings (P/E)23.0
Beta1.02
Next Earnings
May 12, 2026EPS Estimate
0.31Next Dividend Ex-DateN/A
Dividend Yield1.98%
Share Statistics
EPS (TTM)0.29
Shares Outstanding2,256,000,000
10 Day Avg. Volume0
30 Day Avg. Volume1,521
Financial Highlights & Ratios
PEG Ratio7.41
Price to Book (P/B)2.44
Price to Sales (P/S)2.34
P/FCF Ratio24.19
Enterprise Value/Market Cap1.11
Enterprise Value/Revenue2.75
Enterprise Value/Gross Profit6.42
Enterprise Value/Ebitda13.29
Forecast
1Y Price Target
$28.00Price Target Upside7.61% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Profitability And ROESustained mid-to-high margins and an ~11.6% ROE indicate durable profitability typical of established med-tech firms. This margin profile supports internal R&D, service networks and dividend capacity, helping the company absorb cyclical revenue swings and fund strategic initiatives over the medium term.
Recurring Revenue From Installed BaseA large installed base with consumables and multi-year service contracts creates annuity-like revenue that stabilizes cash flow and margins. These recurring streams reduce sensitivity to single-sale cycles, support predictable FCF, and provide a platform to upsell software and upgrades over multiple years.
Imaging And Precision Therapy MomentumSustained operational margin expansion in core Imaging and Precision Therapy reflects improved mix, cost discipline and synergies (including Varian). Durable margin uplift implies stronger cash generation per unit of revenue and supports reinvestment in innovation and commercial expansion despite macro headwinds.
Bears Say
Diagnostics China DisruptionStructural policy changes in China (VBP, reimbursement cuts) have reduced prices, volumes and profit conversion for Diagnostics. Because China is a large market, sustained regulatory-driven headwinds can materially compress segment revenue, limit consumables growth, and depress margin conversion over the coming quarters.
Volatile Free Cash FlowWhile FCF is positive, the ~20% TTM decline and uneven conversion show cash generation volatility driven by working capital and capex timing. Persistent variability hampers reliable funding for capex, debt reduction or M&A, reducing strategic flexibility if revenue growth remains soft.
Material Absolute Debt And LeverageA moderately high leverage profile and large absolute debt balance constrain balance-sheet flexibility. If revenue or FCF growth slows, servicing and refinancing risks rise and management's ability to pursue sizable M&A, buybacks or rapid deleveraging is limited, increasing sensitivity to cash flow shocks.
Siemens Healthineers AG Unsponsored ADR News
SMMNY FAQ
What was Siemens Healthineers AG Unsponsored ADR’s price range in the past 12 months?
Siemens Healthineers AG Unsponsored ADR lowest stock price was $23.42 and its highest was $29.14 in the past 12 months.
What is Siemens Healthineers AG Unsponsored ADR’s market cap?
Siemens Healthineers AG Unsponsored ADR’s market cap is $54.44B.
When is Siemens Healthineers AG Unsponsored ADR’s upcoming earnings report date?
Siemens Healthineers AG Unsponsored ADR’s upcoming earnings report date is May 12, 2026 which is in 78 days.
How were Siemens Healthineers AG Unsponsored ADR’s earnings last quarter?
Siemens Healthineers AG Unsponsored ADR released its earnings results on Jan 29, 2026. The company reported $0.289 earnings per share for the quarter, beating the consensus estimate of $0.263 by $0.026.
Is Siemens Healthineers AG Unsponsored ADR overvalued?
According to Wall Street analysts Siemens Healthineers AG Unsponsored ADR’s price is currently Undervalued.
Does Siemens Healthineers AG Unsponsored ADR pay dividends?
Siemens Healthineers AG Unsponsored ADR pays a Annually dividend of $0.521 which represents an annual dividend yield of 1.98%. See more information on Siemens Healthineers AG Unsponsored ADR dividends here
What is Siemens Healthineers AG Unsponsored ADR’s EPS estimate?
Siemens Healthineers AG Unsponsored ADR’s EPS estimate is 0.31.
How many shares outstanding does Siemens Healthineers AG Unsponsored ADR have?
Siemens Healthineers AG Unsponsored ADR has 2,256,000,000 shares outstanding.
What happened to Siemens Healthineers AG Unsponsored ADR’s price movement after its last earnings report?
Siemens Healthineers AG Unsponsored ADR reported an EPS of $0.289 in its last earnings report, beating expectations of $0.263. Following the earnings report the stock price went down -1.108%.
Which hedge fund is a major shareholder of Siemens Healthineers AG Unsponsored ADR?
Currently, no hedge funds are holding shares in SMMNY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Siemens Healthineers AG Unsponsored ADR Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$28.00 (7.61% Upside)
$28.00 (7.61% Upside)
Crowd Wisdom
Very Positive
Last 7 Days ▲ 34.7%
Last 30 Days ▲ 20.9%
Last 30 Days ▲ 20.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-6.89%
12-Months-Change
Fundamentals
Return on Equity
11.46%
Trailing 12-Months
Asset Growth
1.43%
Trailing 12-Months
Company Description
Siemens Healthineers AG Unsponsored ADR
Siemens Healthineers AG Unsponsored ADR (SMMNY) is a global leader in medical technology and healthcare solutions, providing innovative and high-quality products and services in the fields of imaging, diagnostics, and digital health. The company operates primarily in the healthcare sector, focusing on areas such as imaging systems (including MRI, CT, and ultrasound), laboratory diagnostics, and advanced therapies. Siemens Healthineers aims to enhance patient care by delivering cutting-edge technologies and solutions that improve clinical outcomes and operational efficiency in healthcare settings.
SMMNY Company Deck
SMMNY Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a mix of strong operational performance in Imaging and Precision Therapy (solid growth, margin expansion ex-headwinds, strong Americas performance, product and partnership momentum, and a Moody's investment-grade rating) offset by significant challenges in Diagnostics driven by China-specific structural changes (VBP and reimbursement reductions), tariff and FX headwinds, and near-term guidance caution for Q2. Management emphasized that core synergies and operational improvements largely offset macro headwinds in Q1 and confirmed the full-year outlook, but Diagnostics and China pose material, near-term headwinds that may temper segment-level performance.View all SMMNY earnings summariesSMMNY Stock 12 Month Forecast
Average Price Target
$28.00
▲(7.61% Upside)
Technical Analysis
Ownership Overview
―
Insiders
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---